SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062017
Filing Date
2023-11-09
Accepted
2023-11-09 16:06:11
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20231109.htm   iXBRL 8-K 48438
2 EX-99.1 meip-ex99_1.htm EX-99.1 201153
3 GRAPHIC img183464774_0.jpg GRAPHIC 80752
  Complete submission text file 0000950170-23-062017.txt   486064

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20231109.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20231109_lab.xml EX-101.LAB 12806
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20231109_pre.xml EX-101.PRE 9455
8 EXTRACTED XBRL INSTANCE DOCUMENT meip-20231109_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 231392331
SIC: 2834 Pharmaceutical Preparations